Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 66

1.

Is Bone Loss or Devascularization Associated With Recurrence of Osteomyelitis in Wartime Open Tibia Fractures?

Petfield JL, Tribble DR, Potter BK, Lewandowski LR, Weintrob AC, Krauss M, Murray CK, Stinner DJ; Trauma Infectious Disease Outcomes Study Group.

Clin Orthop Relat Res. 2019 Apr;477(4):789-801. doi: 10.1097/CORR.0000000000000411.

PMID:
30901004
2.

Osteomyelitis Risk Factors Related to Combat Trauma Open Femur Fractures: A Case-Control Analysis.

Lewandowski LR, Potter BK, Murray CK, Petfield J, Stinner DJ, Krauss M, Weintrob AC, Tribble DR; Trauma Infectious Disease Outcomes Study Group.

J Orthop Trauma. 2019 Apr;33(4):e110-e119. doi: 10.1097/BOT.0000000000001397.

PMID:
30570616
3.

Combat-Related Invasive Fungal Infections: Development of a Clinically Applicable Clinical Decision Support System for Early Risk Stratification.

Potter BK, Forsberg JA, Silvius E, Wagner M, Khatri V, Schobel SA, Belard AJ, Weintrob AC, Tribble DR, Elster EA.

Mil Med. 2019 Jan 1;184(1-2):e235-e242. doi: 10.1093/milmed/usy182. No abstract available. Erratum in: Mil Med. 2018 Nov 1;183(11-12):329.

PMID:
30124943
4.

Early Infections Complicating the Care of Combat Casualties from Iraq and Afghanistan.

Weintrob AC, Murray CK, Xu J, Krauss M, Bradley W, Warkentien TE, Lloyd BA, Tribble DR.

Surg Infect (Larchmt). 2018 Apr;19(3):286-297. doi: 10.1089/sur.2017.240. Epub 2018 Jan 19.

5.

Epidemiology of Trauma-Related Infections among a Combat Casualty Cohort after Initial Hospitalization: The Trauma Infectious Disease Outcomes Study.

Tribble DR, Krauss MR, Murray CK, Warkentien TE, Lloyd BA, Ganesan A, Greenberg L, Xu J, Li P, Carson ML, Bradley W, Weintrob AC.

Surg Infect (Larchmt). 2018 Jul;19(5):494-503. doi: 10.1089/sur.2017.241. Epub 2018 May 2.

PMID:
29717911
6.

Infectious Complications After Deployment Trauma: Following Wounded US Military Personnel Into Veterans Affairs Care.

McDonald JR, Liang SY, Li P, Maalouf S, Murray CK, Weintrob AC, Schnaubelt ER, Kuhn J, Ganesan A, Bradley W, Tribble DR; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Clin Infect Dis. 2018 Sep 28;67(8):1205-1212. doi: 10.1093/cid/ciy280.

PMID:
29659771
7.

Impact of Operational Theater on Combat and Noncombat Trauma-Related Infections.

Tribble DR, Li P, Warkentien TE, Lloyd BA, Schnaubelt ER, Ganesan A, Bradley W, Aggarwal D, Carson ML, Weintrob AC, Murray CK.

Mil Med. 2016 Oct;181(10):1258-1268.

8.

Histopathological techniques for the diagnosis of combat-related invasive fungal wound infections.

Heaton SM, Weintrob AC, Downing K, Keenan B, Aggarwal D, Shaikh F, Tribble DR, Wells J; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

BMC Clin Pathol. 2016 Jul 7;16:11. doi: 10.1186/s12907-016-0033-9. eCollection 2016.

9.

Isolation of Rapidly Growing Nontuberculous Mycobacteria in Wounds Following Combat-Related Injury.

Fiske LC, Homeyer DC, Zapor M, Hartzell J, Warkentien T, Weintrob AC, Ganesan A, Burgess T, Snesrud E, Waterman P, Nielsen L, Ressner RA.

Mil Med. 2016 Jun;181(6):530-6. doi: 10.7205/MILMED-D-14-00731.

PMID:
27244062
10.

MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity.

Utay NS, Roque A, Timmer JK, Morcock DR, DeLeage C, Somasunderam A, Weintrob AC, Agan BK, Estes JD, Crum-Cianflone NF, Douek DC.

PLoS Pathog. 2016 Apr 19;12(4):e1005580. doi: 10.1371/journal.ppat.1005580. eCollection 2016 Apr.

11.

Multidrug-resistant gram-negative bacilli colonization risk factors among trauma patients.

Gilbert LJ, Li P, Murray CK, Yun HC, Aggarwal D, Weintrob AC, Tribble DR; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Diagn Microbiol Infect Dis. 2016 Apr;84(4):358-60. doi: 10.1016/j.diagmicrobio.2015.12.014. Epub 2015 Dec 23.

12.

Tranexamic acid in life-threatening military injury and the associated risk of infective complications.

Lewis CJ, Li P, Stewart L, Weintrob AC, Carson ML, Murray CK, Tribble DR, Ross JD.

Br J Surg. 2016 Mar;103(4):366-73. doi: 10.1002/bjs.10055. Epub 2016 Jan 21.

13.

Epidemiology and antimicrobial susceptibilities of wound isolates of obligate anaerobes from combat casualties.

White BK, Mende K, Weintrob AC, Beckius ML, Zera WC, Lu D, Bradley W, Tribble DR, Schnaubelt ER, Murray CK; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcome Study Group.

Diagn Microbiol Infect Dis. 2016 Feb;84(2):144-50. doi: 10.1016/j.diagmicrobio.2015.10.010. Epub 2015 Oct 23.

14.

Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load.

McLaren PJ, Coulonges C, Bartha I, Lenz TL, Deutsch AJ, Bashirova A, Buchbinder S, Carrington MN, Cossarizza A, Dalmau J, De Luca A, Goedert JJ, Gurdasani D, Haas DW, Herbeck JT, Johnson EO, Kirk GD, Lambotte O, Luo M, Mallal S, van Manen D, Martinez-Picado J, Meyer L, Miro JM, Mullins JI, Obel N, Poli G, Sandhu MS, Schuitemaker H, Shea PR, Theodorou I, Walker BD, Weintrob AC, Winkler CA, Wolinsky SM, Raychaudhuri S, Goldstein DB, Telenti A, de Bakker PI, Zagury JF, Fellay J.

Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):14658-63. doi: 10.1073/pnas.1514867112. Epub 2015 Nov 9.

15.

Environmental Factors Related to Fungal Wound Contamination after Combat Trauma in Afghanistan, 2009-2011.

Tribble DR, Rodriguez CJ, Weintrob AC, Shaikh F, Aggarwal D, Carson ML, Murray CK, Masuoka P; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Emerg Infect Dis. 2015 Oct;21(10):1759-69. doi: 10.3201/eid2110.141759.

16.

Early Complications and Outcomes in Combat Injury-Related Invasive Fungal Wound Infections: A Case-Control Analysis.

Lewandowski LR, Weintrob AC, Tribble DR, Rodriguez CJ, Petfield J, Lloyd BA, Murray CK, Stinner D, Aggarwal D, Shaikh F, Potter BK; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

J Orthop Trauma. 2016 Mar;30(3):e93-9. doi: 10.1097/BOT.0000000000000447.

17.

Impact of Mucorales and Other Invasive Molds on Clinical Outcomes of Polymicrobial Traumatic Wound Infections.

Warkentien TE, Shaikh F, Weintrob AC, Rodriguez CJ, Murray CK, Lloyd BA, Ganesan A, Aggarwal D, Carson ML, Tribble DR; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

J Clin Microbiol. 2015 Jul;53(7):2262-70. doi: 10.1128/JCM.00835-15. Epub 2015 May 13.

18.

Resistance patterns and clinical significance of Candida colonization and infection in combat-related injured patients from iraq and afghanistan.

Blyth DM, Mende K, Weintrob AC, Beckius ML, Zera WC, Bradley W, Lu D, Tribble DR, Murray CK.

Open Forum Infect Dis. 2014 Dec 16;1(3):ofu109. doi: 10.1093/ofid/ofu109. eCollection 2014 Dec.

19.

Healthcare-associated pneumonia among U.S. combat casualties, 2009 to 2010.

Yun HC, Weintrob AC, Conger NG, Li P, Lu D, Tribble DR, Murray CK; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Mil Med. 2015 Jan;180(1):104-10. doi: 10.7205/MILMED-D-14-00209.

20.

Clinical relevance of mold culture positivity with and without recurrent wound necrosis following combat-related injuries.

Rodriguez C, Weintrob AC, Dunne JR, Weisbrod AB, Lloyd B, Warkentien T, Malone D, Wells J, Murray CK, Bradley W, Shaikh F, Shah J, Carson ML, Aggarwal D, Tribble DR; the Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Investigative Team.

J Trauma Acute Care Surg. 2014 Nov;77(5):769-773.

21.

A single dose of benzathine penicillin G is as effective as multiple doses of benzathine penicillin G for the treatment of HIV-infected persons with early syphilis.

Ganesan A, Mesner O, Okulicz JF, O'Bryan T, Deiss RG, Lalani T, Whitman TJ, Weintrob AC, Macalino G, Agan BK; Infectious Disease Clinical Research Program HIV/STI Working Group.

Clin Infect Dis. 2015 Feb 15;60(4):653-60. doi: 10.1093/cid/ciu888. Epub 2014 Nov 10.

22.

Phenotypic and genotypic changes over time and across facilities of serial colonizing and infecting Escherichia coli isolates recovered from injured service members.

Mende K, Beckius ML, Zera WC, Yu X, Cheatle KA, Aggarwal D, Li P, Lloyd BA, Tribble DR, Weintrob AC, Murray CK.

J Clin Microbiol. 2014 Nov;52(11):3869-77. doi: 10.1128/JCM.00821-14. Epub 2014 Aug 20.

23.

Effect of early screening for invasive fungal infections in U.S. service members with explosive blast injuries.

Lloyd B, Weintrob AC, Rodriguez C, Dunne JR, Weisbrod AB, Hinkle M, Warkentien T, Murray CK, Oh J, Millar EV, Shah J, Shaikh F, Gregg S, Lloyd G, Stevens J, Carson ML, Aggarwal D, Tribble DR; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Surg Infect (Larchmt). 2014 Oct;15(5):619-26. doi: 10.1089/sur.2012.245. Epub 2014 May 13.

24.

Risk factors associated with invasive fungal infections in combat trauma.

Rodriguez CJ, Weintrob AC, Shah J, Malone D, Dunne JR, Weisbrod AB, Lloyd BA, Warkentien TE, Murray CK, Wilkins K, Shaikh F, Carson ML, Aggarwal D, Tribble DR; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Surg Infect (Larchmt). 2014 Oct;15(5):521-6. doi: 10.1089/sur.2013.123. Epub 2014 May 12.

25.

Compliance with antimalarial chemoprophylaxis recommendations for wounded United States military personnel admitted to a military treatment facility.

Rini EA, Weintrob AC, Tribble DR, Lloyd BA, Warkentien TE, Shaikh F, Li P, Aggarwal D, Carson ML, Murray CK; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Am J Trop Med Hyg. 2014 Jun;90(6):1113-6. doi: 10.4269/ajtmh.13-0646. Epub 2014 Apr 14.

26.

Biofilms and persistent wound infections in United States military trauma patients: a case-control analysis.

Akers KS, Mende K, Cheatle KA, Zera WC, Yu X, Beckius ML, Aggarwal D, Li P, Sanchez CJ, Wenke JC, Weintrob AC, Tribble DR, Murray CK; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

BMC Infect Dis. 2014 Apr 8;14:190. doi: 10.1186/1471-2334-14-190.

27.

HIV outcomes in Hepatitis B virus coinfected individuals on HAART.

Chun HM, Mesner O, Thio CL, Bebu I, Macalino G, Agan BK, Bradley WP, Malia J, Peel SA, Jagodzinski LL, Weintrob AC, Ganesan A, Bavaro M, Maguire JD, Landrum ML; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2014 Jun 1;66(2):197-205. doi: 10.1097/QAI.0000000000000142.

28.

Combat trauma-associated invasive fungal wound infections: epidemiology and clinical classification.

Weintrob AC, Weisbrod AB, Dunne JR, Rodriguez CJ, Malone D, Lloyd BA, Warkentien TE, Wells J, Murray CK, Bradley W, Shaikh F, Shah J, Aggarwal D, Carson ML, Tribble DR; Infectious Disease Clinical Research Program Trauma Infectious Disease Outcomes Study Group.

Epidemiol Infect. 2015 Jan;143(1):214-24. doi: 10.1017/S095026881400051X. Epub 2014 Mar 18.

29.

Adherence to published antimicrobial prophylaxis guidelines for wounded service members in the ongoing conflicts in Southwest Asia.

Lloyd BA, Weintrob AC, Hinkle MK, Fortuna GR, Murray CK, Bradley W, Millar EV, Shaikh F, Vanderzant K, Gregg S, Lloyd G, Stevens J, Carson ML, Aggarwal D, Tribble DR.

Mil Med. 2014 Mar;179(3):324-8. doi: 10.7205/MILMED-D-13-00424.

30.

Race/ethnicity and HAART initiation in a military HIV infected cohort.

Johnson EN, Roediger MP, Landrum ML, Crum-Cianflone NF, Weintrob AC, Ganesan A, Okulicz JF, Macalino GE, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

AIDS Res Ther. 2014 Jan 24;11(1):10. doi: 10.1186/1742-6405-11-10.

31.

The VACS index predicts mortality in a young, healthy HIV population starting highly active antiretroviral therapy.

Bebu I, Tate J, Rimland D, Mesner O, Macalino GE, Ganesan A, Okulicz JF, Bavaro M, Weintrob AC, Justice AC, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2014 Feb 1;65(2):226-30. doi: 10.1097/QAI.0000000000000045.

32.

Active surveillance for asymptomatic colonization with multidrug-resistant gram negative bacilli among injured service members--a three year evaluation.

Weintrob AC, Murray CK, Lloyd B, Li P, Lu D, Miao Z, Aggarwal D, Carson ML, Gaskins LJ, Tribble DR.

MSMR. 2013 Aug;20(8):17-22.

33.

Evaluation for a novel methicillin resistance (mecC) homologue in methicillin-resistant Staphylococcus aureus isolates obtained from injured military personnel.

Ganesan A, Crawford K, Mende K, Murray CK, Lloyd B, Ellis M, Tribble DR, Weintrob AC.

J Clin Microbiol. 2013 Sep;51(9):3073-5. doi: 10.1128/JCM.01516-13. Epub 2013 Jun 19.

34.

A comparison of HAART outcomes between the US military HIV Natural History Study (NHS) and HIV Atlanta Veterans Affairs Cohort Study (HAVACS).

Guest JL, Weintrob AC, Rimland D, Rentsch C, Bradley WP, Agan BK, Marconi VC; I D C R P H I V Working Group.

PLoS One. 2013 May 1;8(5):e62273. doi: 10.1371/journal.pone.0062273. Print 2013.

35.

Vitamin D deficiency and its association with low bone mineral density, HIV-related factors, hospitalization, and death in a predominantly black HIV-infected cohort.

Sherwood JE, Mesner OC, Weintrob AC, Hadigan CM, Wilkins KJ, Crum-Cianflone NF, Aronson NE.

Clin Infect Dis. 2012 Dec;55(12):1727-36. doi: 10.1093/cid/cis785. Epub 2012 Sep 12.

36.

The elution of colistimethate sodium from polymethylmethacrylate and calcium phosphate cement beads.

Waterman P, Barber M, Weintrob AC, VanBrakle R, Howard R, Kozar MP, Andersen R, Wortmann G.

Am J Orthop (Belle Mead NJ). 2012 Jun;41(6):256-9.

PMID:
22837988
37.

Determinants of incident chronic kidney disease and progression in a cohort of HIV-infected persons with unrestricted access to health care.

Ganesan A, Krantz EM, Huppler Hullsiek K, Riddle MS, Weintrob AC, Lalani T, Okulicz JF, Landrum M, Agan B, Whitman TJ, Ross MJ, Crum-Cianflone NF; Infectious Disease Clinical Research Program HIV/STI Working Group.

HIV Med. 2013 Feb;14(2):65-76. doi: 10.1111/j.1468-1293.2012.01036.x. Epub 2012 Jul 19.

38.

Fine-mapping classical HLA variation associated with durable host control of HIV-1 infection in African Americans.

McLaren PJ, Ripke S, Pelak K, Weintrob AC, Patsopoulos NA, Jia X, Erlich RL, Lennon NJ, Kadie CM, Heckerman D, Gupta N, Haas DW, Deeks SG, Pereyra F, Walker BD, de Bakker PI; International HIV Controllers Study.

Hum Mol Genet. 2012 Oct 1;21(19):4334-47. doi: 10.1093/hmg/dds226. Epub 2012 Jun 19.

39.

Hepatitis B vaccine antibody response and the risk of clinical AIDS or death.

Landrum ML, Hullsiek KH, O'Connell RJ, Chun HM, Ganesan A, Okulicz JF, Lalani T, Weintrob AC, Crum-Cianflone NF, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

PLoS One. 2012;7(3):e33488. doi: 10.1371/journal.pone.0033488. Epub 2012 Mar 22.

40.

Gonorrhoea or chlamydia in a U.S. military HIV-positive cohort.

Spaulding AB, Lifson AR, Iverson ER, Ganesan A, Landrum ML, Weintrob AC, Agan BK, Bavaro MF, O'Connell RJ, Macalino GE; Infectious Disease Clinical Research Program HIV Working Group.

Sex Transm Infect. 2012 Jun;88(4):266-71. doi: 10.1136/sextrans-2011-050173. Epub 2012 Jan 4.

PMID:
22223813
41.

Hepatitis B virus coinfection negatively impacts HIV outcomes in HIV seroconverters.

Chun HM, Roediger MP, Hullsiek KH, Thio CL, Agan BK, Bradley WP, Peel SA, Jagodzinski LL, Weintrob AC, Ganesan A, Wortmann G, Crum-Cianflone NF, Maguire JD, Landrum ML; Infectious Disease Clinical Research Program HIV Working Group.

J Infect Dis. 2012 Jan 15;205(2):185-93. doi: 10.1093/infdis/jir720. Epub 2011 Dec 5.

42.

Development of chronic hepatitis B virus infection in hepatitis B surface antigen negative HIV/HBV co-infected adults: a rare opportunistic illness.

Landrum ML, Roediger MP, Fieberg AM, Weintrob AC, Okulicz JF, Crum-Cianflone NF, Ganesan A, Lalani T, Macalino GE, Chun HM.

J Med Virol. 2011 Sep;83(9):1537-43. doi: 10.1002/jmv.22155.

PMID:
21739443
43.

Elevated CD8 counts during HAART are associated with HIV virologic treatment failure.

Krantz EM, Hullsiek KH, Okulicz JF, Weintrob AC, Agan BK, Crum-Cianflone NF, Ganesan A, Ferguson TM, Hale BR; Infectious Disease Clinical Research Program HIV Working Group.

J Acquir Immune Defic Syndr. 2011 Aug 15;57(5):396-403. doi: 10.1097/QAI.0b013e318221c62a.

44.

Virologic outcomes of HAART with concurrent use of cytochrome P450 enzyme-inducing antiepileptics: a retrospective case control study.

Okulicz JF, Grandits GA, French JA, George JM, Simpson DM, Birbeck GL, Ganesan A, Weintrob AC, Crum-Cianflone N, Lalani T, Landrum ML; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group.

AIDS Res Ther. 2011 May 16;8:18. doi: 10.1186/1742-6405-8-18.

45.

Long-term safety and serologic response to measles, mumps, and rubella vaccination in HIV-1 infected adults.

Stermole BM, Grandits GA, Roediger MP, Clark BM, Ganesan A, Weintrob AC, Crum-Cianflone NF, Ferguson TM, Macalino GE, Landrum ML.

Vaccine. 2011 Apr 5;29(16):2874-80. doi: 10.1016/j.vaccine.2011.02.013. Epub 2011 Feb 23.

46.

Long-term CD4+ lymphocyte response following HAART initiation in a U.S. Military prospective cohort.

Lifson AR, Krantz EM, Eberly LE, Dolan MJ, Marconi VC, Weintrob AC, Crum-Cianflone NF, Ganesan A, Grambsch PL, Agan BK; Infectious Disease Clinical Research Program (IDCRP) HIV Working Group.

AIDS Res Ther. 2011 Jan 18;8(1):2. doi: 10.1186/1742-6405-8-2.

47.

The timing of hepatitis B virus (HBV) immunization relative to human immunodeficiency virus (HIV) diagnosis and the risk of HBV infection following HIV diagnosis.

Landrum ML, Hullsiek KH, Chun HM, Crum-Cianflone NF, Ganesan A, Weintrob AC, Barthel RV, O'Connell RJ, Agan BK.

Am J Epidemiol. 2011 Jan 1;173(1):84-93. doi: 10.1093/aje/kwq326. Epub 2010 Nov 4.

48.

Outcomes of highly active antiretroviral therapy in the context of universal access to healthcare: the U.S. Military HIV Natural History Study.

Marconi VC, Grandits GA, Weintrob AC, Chun H, Landrum ML, Ganesan A, Okulicz JF, Crum-Cianflone N, O'Connell RJ, Lifson A, Wortmann GW, Agan BK; Infectious Disease Clinical Research Program HIV Working Group (IDCRP).

AIDS Res Ther. 2010 May 27;7:14. doi: 10.1186/1742-6405-7-14.

49.

CD4 T cell count reconstitution in HIV controllers after highly active antiretroviral therapy.

Okulicz JF, Grandits GA, Weintrob AC, Landrum ML, Ganesan A, Crum-Cianflone NF, Agan BK, Marconi VC.

Clin Infect Dis. 2010 Apr 15;50(8):1187-91. doi: 10.1086/651421.

PMID:
20218878
50.

Obesity among HIV-infected persons: impact of weight on CD4 cell count.

Crum-Cianflone NF, Roediger M, Eberly LE, Vyas K, Landrum ML, Ganesan A, Weintrob AC, Barthel RV, Agan BK; Infectious Disease Clinical Research Program HIV Working Group.

AIDS. 2010 Apr 24;24(7):1069-72. doi: 10.1097/QAD.0b013e328337fe01.

Supplemental Content

Loading ...
Support Center